What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Mutation
His primary scientific interests are in Internal medicine, Cardiology, Cardiomyopathy, Arrhythmogenic right ventricular dysplasia and Marfan syndrome.
His Internal medicine study typically links adjacent topics like Endocrinology.
His work in Cardiology addresses subjects such as Genetic testing, which are connected to disciplines such as MEDLINE and Intensive care medicine.
His Cardiomyopathy research incorporates themes from Heart disease, Dilated cardiomyopathy, Sudden death and Ventricular fibrillation.
Daniel P. Judge has included themes like Penetrance, Sudden cardiac death and Ventricular tachycardia in his Arrhythmogenic right ventricular dysplasia study.
The study incorporates disciplines such as Aortic aneurysm and Aorta in addition to Marfan syndrome.
His most cited work include:
- Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. (1347 citations)
- A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 (1278 citations)
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) (1076 citations)
What are the main themes of his work throughout his whole career to date?
Daniel P. Judge mainly investigates Internal medicine, Cardiology, Cardiomyopathy, Arrhythmogenic right ventricular dysplasia and Heart failure.
His Internal medicine study frequently draws parallels with other fields, such as Endocrinology.
His Ejection fraction, Right ventricular cardiomyopathy, Dilated cardiomyopathy and Implantable cardioverter-defibrillator study, which is part of a larger body of work in Cardiology, is frequently linked to In patient, bridging the gap between disciplines.
His Cardiomyopathy research is multidisciplinary, incorporating perspectives in Gene mutation, Disease, Pathology, Penetrance and Sudden cardiac death.
His studies in Pathology integrate themes in fields like Marfan syndrome and Fibrillin.
His work deals with themes such as Proband, Mutation, Ventricular fibrillation, Electrocardiography and Heart disease, which intersect with Arrhythmogenic right ventricular dysplasia.
He most often published in these fields:
- Internal medicine (70.29%)
- Cardiology (56.87%)
- Cardiomyopathy (56.87%)
What were the highlights of his more recent work (between 2017-2021)?
- Cardiomyopathy (56.87%)
- Internal medicine (70.29%)
- Cardiology (56.87%)
In recent papers he was focusing on the following fields of study:
Daniel P. Judge mostly deals with Cardiomyopathy, Internal medicine, Cardiology, Transthyretin and Amyloidosis.
Daniel P. Judge interconnects Phenotype, Dilated cardiomyopathy, Disease and Sudden cardiac death in the investigation of issues within Cardiomyopathy.
Internal medicine is a component of his Cardiac amyloidosis, Heart failure and Ventricular assist device studies.
Cardiology connects with themes related to Genetic testing in his study.
His Amyloid cardiomyopathy study in the realm of Transthyretin connects with subjects such as Tafamidis and Placebo.
His work on Attr amyloidosis as part of general Amyloidosis research is often related to In patient, thus linking different fields of science.
Between 2017 and 2021, his most popular works were:
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy (589 citations)
- 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy (148 citations)
- A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy (70 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Mutation
Daniel P. Judge focuses on Cardiomyopathy, Internal medicine, Cardiology, Right ventricular cardiomyopathy and Transthyretin.
His Cardiomyopathy study deals with the bigger picture of Heart failure.
Specifically, his work in Internal medicine is concerned with the study of Amyloidosis.
He is involved in the study of Cardiology that focuses on Cardiac amyloidosis in particular.
His Right ventricular cardiomyopathy research is multidisciplinary, incorporating elements of Genetics, Arrhythmogenic right ventricular dysplasia, Hypertrophic cardiomyopathy, Disease and Penetrance.
His Arrhythmogenic right ventricular dysplasia study incorporates themes from Differential diagnosis and Interquartile range.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
